Manuscripts

Search by keyword, year, or author name.

Showing 1602 manuscripts.

Factors associated with early study discontinuation in AACTG studies, DACS 200

Janet Andersen, Sc.D., Robert J. Fass, M.D., Charles van der Horst, M.D. Factors associated with early study discontinuation in AACTG studies, DACS 200. Contemporary Clinical Trials. 2007 Sep 01; 28(5):583-92.

Year

2007

Journal

Contemporary Clinical Trials

The prevalence and incidence of neurocognitive impairment in the HAART era

Kevin R. Robertson, Ph.D., Marlene Smurzynski, Ph.D., M.S.P.H., Thomas D. Parsons, Ph.D., Kunling Wu, M.S., Ronald J. Bosch, Ph.D., Julia (Wei) Wu, M.S., Justin C. McArthur, M.B.B.S., M.P.H., Ann C. Collier, M.D., Scott Evans, Ph.D., Ronald J. Ellis, M.D.,Ph.D. The prevalence and incidence of neurocognitive impairment in the HAART era. AIDS. 2007 Sep 12; 21(14):1915-21.

Year

2007

Journal

AIDS

Pharmacokinetic evaluation of the effects of ribavirin on zidovudine triphosphate formation: ACTG 5092s study team

Francesca Aweeka, Pharm.D., Minhee Kang, M.S., Ph.D., Ji Young Yu, M.P.H., Patricia S. Lizak, B.S., Beverly L. Alston-Smith, M.D., Raymond T. Chung, M.D. Pharmacokinetic evaluation of the effects of ribavirin on zidovudine triphosphate formation: ACTG 5092s study team. HIV Medicine. 2007 Jun 01; 8(5):288-94.

Year

2007

Journal

HIV Medicine

Virologic response to potent antiretroviral therapy and modeling of HIV dynamics in early pediatric infection.

Paul Palumbo, M.D., Hulin Wu, Ph.D., Ellen Gould Chadwick, M.D., Ping Ruan, Ph.D., Katherine Luzuriaga, M.D., John H. Rodman, Pharm.D., Ram Yogev, M.D. Virologic response to potent antiretroviral therapy and modeling of HIV dynamics in early pediatric infection. Journal of Infectious Diseases. 2007 Jul 01; 196(1):23-29. PMID: 17538879.

Year

2007

Journal

Journal of Infectious Diseases

Intracellular pharmacokinetics of once versus twice daily zidovudine and lamivudine in adolescents.

Patricia M. Flynn, M.D., M.S., John H. Rodman, Pharm.D., Jane C. Lindsey, Sc.D., Brian Robbins, Ph.D., Edmund Capparelli, Pharm.D., Katherine M. Knapp, M.D., Jose F. Rodriguez, Ph.D., James McNamara, M.D., Leslie Serchuck, M.D., Barbara E. Heckman, B.S., Jaime Martinez, M.D. Intracellular pharmacokinetics of once versus twice daily zidovudine and lamivudine in adolescents. Antimicrobial Agents and Chemotherapy. 2007 Oct 01; 51(10):3516-3522. PMID: 17664328; PMCID: PMC2043291.

Year

2007

Journal

Antimicrobial Agents and Chemotherapy

Study

P1012

Population pharmacokinetics of lamivudine in human immunodeficiency virus-exposed and -infected infants.

Adriana H. Tremoulet, Edmund Capparelli, Pharm.D., Pratima K. Patel, Edward P. Acosta, Pharm.D., Katherine Luzuriaga, M.D., Yvonne J. Bryson, M.D., Diane W. Wara, M.D., Diane Holland, M.Phil., Mark Mirochnick, M.D. Population pharmacokinetics of lamivudine in human immunodeficiency virus-exposed and -infected infants. Antimicrobial Agents and Chemotherapy. 2007 Dec 01; 51(12):4297 - 7302. PMID: 17893155; PMCID: PMC2168008.

Year

2007

Journal

Antimicrobial Agents and Chemotherapy

CYP2B6 genetic variants impact the pharmacokinetics of nevirapine and clinical response in HIV-1 infected children receiving HAART.

Akihiko Saitoh, M.D., Elizabeth Sarles, Edmund Capparelli, Pharm.D., Francesca Aweeka, Pharm.D., Andrea Kovacs, M.D., Sandra K. Burchett, M.D., M.S., Andrew A. Wiznia, M.D., Sharon Appelbaum Nachman, M.D., Terence Fenton, Ed.D., Stephen A. Spector, M.D. CYP2B6 genetic variants impact the pharmacokinetics of nevirapine and clinical response in HIV-1 infected children receiving HAART. AIDS. 2007 Oct 18; 21(16):2191 - 2199. PMID: 18090046.

Year

2007

Journal

AIDS

Early archiving and predominance of nonnucleoside reverse transcriptase inhibitor-resistant HIV-1 among recently infected infants born in the United States.

Deborah Persaud, M.D., Paul Palumbo, M.D., Carrie Ziemniak, Jie (Ellen) Chen, M.S., Stuart C. Ray, Michael Hughes, Ph.D., Peter Havens, M.D., Murli Purswani, M.D., Aditya Gaur, M.D., Ellen Gould Chadwick, M.D. Early archiving and predominance of nonnucleoside reverse transcriptase inhibitor-resistant HIV-1 among recently infected infants born in the United States. Journal of Infectious Diseases. 2007 May 15; 195(10):1402-1410. PMID: 17436219.

Year

2007

Journal

Journal of Infectious Diseases

Study

P1030

Long-term safety and efficacy of a once-daily regimen of emtricitabine, didanosine, and efavirenz in HIV-infected, therapy-naive children and adolescents: Pediatric AIDS Clinical Trials Group Protocol P1021.

Ross E. McKinney, Jr., M.D., John H. Rodman, Pharm.D., ChengCheng Hu, Ph.D., Paula Britto, M.S., Michael Hughes, Ph.D., Elizabeth (Betsy) Smith, M.D., Leslie Serchuck, M.D., Alberto A. Ortiz, M.S., Patricia M. Flynn, M.D., M.S., Ram Yogev, M.D., Stephen A. Spector, M.D., Linda Draper (Marillo), B.A., Melissa Scites, B.S., R.N., C.C.R.C., Ruth E. Dickover, Ph.D., Adriana Weinberg, M.D., Coleen K. Cunningham, M.D., Elaine J. Abrams, M.D., M. Robert Blum, Ph.D., Gregory E. Chittick, B.S., Laurie Reynolds, Mobeen H. Rathore, M.D. Long-term safety and efficacy of a once-daily regimen of emtricitabine, didanosine, and efavirenz in HIV-infected, therapy-naive children and adolescents: Pediatric AIDS Clinical Trials Group Protocol P1021. Pediatrics. 2007 Aug 01; 120(2):e416-e423. PMID: 17646352.

Year

2007

Journal

Pediatrics

Study

P1021

Pharmacokinetics and safety of indinavir in human immunodeficiency virus-infected pregnant women.

Jashvant D. Unadkat, Ph.D., Diane W. Wara, M.D., Michael Hughes, Ph.D., Anita A. Mathias, Ph.D., Diane Holland, M.Phil., Mary E. Paul, M.D., James D. Connor, M.D., Sharon Huang, M.S., Bach-Yen Nguyen, M.D., Heather D. Watts, M.D., Lynne M. Mofenson, M.D., F.A.A.P., Elizabeth (Betsy) Smith, M.D., Paul Deutsch, M.D., Ph.D., Kathleen A. Kaiser, A.A.S., Ruth E. Tuomala, M.D. Pharmacokinetics and safety of indinavir in human immunodeficiency virus-infected pregnant women. Antimicrobial Agents and Chemotherapy. 2007 Feb 01; 51(2):783 - 786. PMID: 17158945; PMCID: PMC1797783.

Year

2007

Journal

Antimicrobial Agents and Chemotherapy